Next Post

Medtech Startup CoreTissue BioEngineering to Be the First Japanese Startup at JPOD @ Boston

YOKOHAMA, Japan, March 16, 2022–(Organization WIRE)–CoreTissue BioEngineering Inc., a health care device firm producing an synthetic ligament derived from decellularized animal tissue, was approved into Johnson & Johnson Innovation – JPOD @ Boston. CoreTissue BioEngineering will develop its footprint and speed up company progress in the US via its aid […]

Subscribe US Now